Adler G

References (4)

Title : The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions - Adler_2014_Int.J.Clin.Pract_68_465
Author(s) : Adler G , Mueller B , Articus K
Ref : Int J Clin Pract , 68 :465 , 2014
Abstract :
PubMedSearch : Adler_2014_Int.J.Clin.Pract_68_465
PubMedID: 24588972

Title : Rationale for transdermal drug administration in Alzheimer disease - Oertel_2007_Neurology_69_S4
Author(s) : Oertel W , Ross JS , Eggert K , Adler G
Ref : Neurology , 69 :S4 , 2007
Abstract :
PubMedSearch : Oertel_2007_Neurology_69_S4
PubMedID: 17646621

Title : Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial - Brassen_2003_Pharmacopsychiatry_36_304
Author(s) : Brassen S , Adler G
Ref : Pharmacopsychiatry , 36 :304 , 2003
Abstract :
PubMedSearch : Brassen_2003_Pharmacopsychiatry_36_304
PubMedID: 14663655

Title : Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients - Adler_2001_Neuropsychobiology_43_273
Author(s) : Adler G , Brassen S
Ref : Neuropsychobiology , 43 :273 , 2001
Abstract :
PubMedSearch : Adler_2001_Neuropsychobiology_43_273
PubMedID: 11340368